UNIGE document Scientific Article
previous document  unige:101397  next document
add to browser collection

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Weitz, Jeffrey I
Lensing, Anthonie W A
Prins, Martin H
Bauersachs, Rupert
Beyer-Westendorf, Jan
Brighton, Timothy A
Cohen, Alexander T
show hidden authors show all authors [1 - 20]
Published in New England Journal of Medicine. 2017, vol. 376, no. 13, p. 1211-1222
Abstract Although many patients with venous thromboembolism require extended treatment, it is uncertain whether it is better to use full- or lower-intensity anticoagulation therapy or aspirin.
Keywords AdultAgedAspirin/administration & dosage/adverse effectsDouble-Blind MethodDrug Administration ScheduleFactor Xa Inhibitors/administration & dosage/adverse effectsFemaleHemorrhage/chemically inducedHumansIntention to Treat AnalysisKaplan-Meier EstimateMaleMiddle AgedPlatelet Aggregation Inhibitors/administration & dosage/adverse effectsRivaroxaban/administration & dosage/adverse effectsSecondary PreventionVenous Thromboembolism/mortality/prevention & control
PMID: 28316279
Full text
Article (Published version) (283 Kb) - public document Free access
Research group La maladie thromboembolique veineuse (808)
(ISO format)
WEITZ, Jeffrey I et al. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism. In: New England Journal of Medicine, 2017, vol. 376, n° 13, p. 1211-1222. doi: 10.1056/NEJMoa1700518 https://archive-ouverte.unige.ch/unige:101397

300 hits



Deposited on : 2018-01-16

Export document
Format :
Citation style :